Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9178 |
High Similarity |
NPD4584 |
Approved |
0.9161 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8725 |
High Similarity |
NPD2420 |
Approved |
0.8725 |
High Similarity |
NPD2421 |
Approved |
0.8562 |
High Similarity |
NPD4017 |
Approved |
0.8438 |
Intermediate Similarity |
NPD3051 |
Approved |
0.8428 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD3110 |
Approved |
0.8414 |
Intermediate Similarity |
NPD3109 |
Approved |
0.8397 |
Intermediate Similarity |
NPD7298 |
Approved |
0.8344 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD3639 |
Approved |
0.8312 |
Intermediate Similarity |
NPD3641 |
Approved |
0.8312 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.8311 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD2970 |
Approved |
0.8272 |
Intermediate Similarity |
NPD2969 |
Approved |
0.8239 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8232 |
Intermediate Similarity |
NPD8252 |
Approved |
0.8232 |
Intermediate Similarity |
NPD8251 |
Approved |
0.8232 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.8221 |
Intermediate Similarity |
NPD27 |
Approved |
0.8221 |
Intermediate Similarity |
NPD2489 |
Approved |
0.8221 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.8194 |
Intermediate Similarity |
NPD6031 |
Approved |
0.8194 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8182 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.8151 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.811 |
Intermediate Similarity |
NPD2898 |
Approved |
0.8105 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7973 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7941 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7941 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7935 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7935 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7895 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7891 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7844 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7836 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7821 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD5754 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7763 |
Intermediate Similarity |
NPD6896 |
Approved |
0.775 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7733 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7722 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7701 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7673 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD2488 |
Approved |
0.767 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7625 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5977 |
Approved |
0.761 |
Intermediate Similarity |
NPD1424 |
Approved |
0.76 |
Intermediate Similarity |
NPD5156 |
Approved |
0.76 |
Intermediate Similarity |
NPD5155 |
Approved |
0.759 |
Intermediate Similarity |
NPD7400 |
Phase 3 |
0.7558 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7533 |
Intermediate Similarity |
NPD3594 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2606 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2605 |
Approved |
0.7533 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7515 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6687 |
Approved |
0.75 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7467 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7467 |
Intermediate Similarity |
NPD3635 |
Approved |
0.7459 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7459 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7459 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7458 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7442 |
Intermediate Similarity |
NPD5313 |
Approved |
0.744 |
Intermediate Similarity |
NPD6037 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD1914 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7377 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7326 |
Intermediate Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD7294 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7297 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4726 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4725 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4721 |
Approved |
0.7273 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7257 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD6747 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD4257 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4256 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD3301 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD7262 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7034 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD4107 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6612 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1024 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7143 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2226 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5938 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7088 |
Intermediate Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5708 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6025 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD1421 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1420 |
Approved |
0.7083
|
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |